Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Guilford Pharmaceuticals has initiated a Phase III clinical development program for Aquavan injection, a novel sedative/hypnotic that is a proprietary water-soluble prodrug of propofol.

In the Pipeline